IRIS PubliCatt

Cassano, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.332
EU - Europa 3.329
AS - Asia 919
AF - Africa 36
SA - Sud America 6
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.631
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.317
DE - Germania 1.331
SE - Svezia 607
CN - Cina 366
IT - Italia 336
PL - Polonia 297
SG - Singapore 281
IE - Irlanda 137
GB - Regno Unito 136
UA - Ucraina 136
FR - Francia 117
ID - Indonesia 83
IN - India 73
RU - Federazione Russa 65
FI - Finlandia 58
TR - Turchia 38
BE - Belgio 35
CI - Costa d'Avorio 35
IR - Iran 24
HK - Hong Kong 14
VN - Vietnam 14
CA - Canada 12
CZ - Repubblica Ceca 12
NL - Olanda 11
CH - Svizzera 8
JP - Giappone 8
LT - Lituania 8
RO - Romania 8
ES - Italia 6
KR - Corea 6
AT - Austria 4
LU - Lussemburgo 4
AU - Australia 3
CL - Cile 3
EU - Europa 3
SA - Arabia Saudita 3
BG - Bulgaria 2
BR - Brasile 2
MD - Moldavia 2
MX - Messico 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BN - Brunei Darussalam 1
CM - Camerun 1
DK - Danimarca 1
EC - Ecuador 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
PA - Panama 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 7.631
Salva come PNG Salva come JPEG
Città #
Chandler 775
Warsaw 283
Ashburn 237
Singapore 219
Fairfield 171
Dublin 136
Wilmington 122
San Mateo 119
Ann Arbor 116
Jacksonville 96
Nürnberg 91
Woodbridge 91
New York 90
Houston 84
Jakarta 83
Nanjing 83
Seattle 69
Cattolica 66
Boston 63
Cambridge 58
Princeton 55
Dearborn 52
Redmond 48
Milan 44
Moscow 43
Marseille 41
Rome 38
Chicago 36
Abidjan 35
Izmir 35
Beijing 34
Brussels 34
Nanchang 31
Redwood City 28
Boardman 26
Bremen 26
Los Angeles 26
Lawrence 25
Helsinki 24
Falls Church 23
London 23
Shanghai 21
Leawood 19
Munich 19
Norwalk 19
Augusta 18
Mountain View 18
Hebei 15
Kraków 14
Dong Ket 13
Hangzhou 13
Kish 12
Jiaxing 11
Lancaster 11
Changsha 10
Shenyang 10
Tianjin 10
Andover 9
Fremont 9
Kunming 9
Paris 9
San Diego 9
Santa Clara 9
Guangzhou 8
Hong Kong 8
Zhengzhou 8
Bologna 7
Simi Valley 7
Busto Arsizio 6
Costa Mesa 6
Detroit 6
Toronto 6
University Park 6
Berlin 5
Brno 5
Changchun 5
Hefei 5
Lanzhou 5
Washington 5
Zurich 5
Caserta 4
Hyderabad 4
Miami 4
Montepulciano 4
Phoenix 4
Prague 4
Sacramento 4
Seoul 4
Vienna 4
Amsterdam 3
Florence 3
Frankfurt am Main 3
Gunzenhausen 3
Helsingborg 3
Hounslow 3
Jinan 3
Lanzo d'Intelvi 3
Mumbai 3
Ningbo 3
Northbrook 3
Totale 4.238
Salva come PNG Salva come JPEG
Nome #
Chance of cure following liver resection for initially unresectable colorectal metastases: analysis of actual 5-year survival 340
Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy 308
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real- world experience 272
Pembrolizumab as first-line treatment for metastatic uveal melanoma 270
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 251
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 206
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 200
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 183
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 164
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 159
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 150
[Gastrointestinal stromal tumors] 142
Thymoma in patients with MG: characteristics and long-term outcome 135
PDGFRA-mutant syndrome 131
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 128
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 128
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 126
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 125
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 124
“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome 118
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 108
Are TKIs favourable for the elderly with non-small-cell lung cancer? 107
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 104
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 104
Trastuzumab-induced corneal ulceration: successful no-drug treatment of a "blind" side effect in a case report 103
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 100
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 93
[Gastrointestinal stromal tumors] 88
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): A randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX 86
Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review. 86
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 84
Advanced colon cancer: staging and prognosis by CEA test 83
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 83
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 83
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 78
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 76
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 74
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 74
eComment. Iterative metastasectomy for recurrent pulmonary disease from colorectal cancer: A challenging issue 73
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 73
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 71
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 71
"Triple positive" early breast cancer: An observational multicenter retrospective analysis of outcome 70
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas 68
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 67
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 66
Divergent gastrointestinal stromal tumors in syndromic settings 65
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 65
Standardizing percutaneous Microwave Ablation in the treatment of Lung Tumors: a prospective multicenter trial (MALT study) 64
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 63
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 63
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 63
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 63
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 63
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 61
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 61
Let‐7a‐5p, mir‐100‐5p, mir‐101‐3p, and mir‐199a‐3p hyperexpression as potential predictive biomarkers in early breast cancer patients 59
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 59
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 58
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 56
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 56
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 55
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 53
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study 52
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 51
Operator learning curve for transradial liver cancer embolization: Implications for the initiation of a transradial access program 51
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 51
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 49
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 49
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 49
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 49
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer 49
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 48
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 45
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting 45
Oral Health Status in Patients with Head and Neck Cancer before Radiotherapy: Baseline Description of an Observational Prospective Study 42
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study 41
Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer. 39
Primary cardiac synovial sarcoma: A review correlating outcomes with surgery and adjuvant therapy 37
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab 36
Targeted therapy in advanced gastric carcinoma: The future is beginning 25
Triple positive breast cancer: A distinct subtype? 25
Cryoablation in Locoregional Management of Complex Unresectable Chest Neoplasms 19
Clinical outcomes of teeth adjacent to the site of mandibulotomy or mandibulectomy in patients with head and neck cancer: results from a multidisciplinary mono-institutional head and neck tumor board 15
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study) 14
Authors' reply “Osteoradionecrosis incidence in preradiation teeth extractions: A prospective study” 11
Osteoradionecrosis incidence in pre‐radiation teeth extractions: A prospective study 9
In reply to the letter to the editor regarding "Clinical outcomes of teeth adjacent to the site of mandibulotomy or mandibulectomy in patients with head and neck cancer: results from a multidisciplinary mono-institutional head and neck tumor board" 8
Totale 7.769
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.619
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020700 0 0 0 0 86 91 126 43 63 74 150 67
2020/2021771 33 108 55 51 86 46 87 19 85 69 105 27
2021/2022965 79 45 21 111 60 40 22 149 52 59 127 200
2022/20231.960 268 274 145 338 96 229 98 187 194 38 66 27
2023/2024778 31 219 31 32 29 119 50 39 13 32 85 98
2024/2025479 36 65 136 98 144 0 0 0 0 0 0 0
Totale 7.769